Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
IsraelRecruitingPHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Pheochromocytoma/Paraganglioma · Pancreatic Neuroendocrine Tumor · Von Hippel-Lindau Disease · Advanced Gastrointestinal Stromal Tumor · HIF-2α Mutated Cancers
Locations
- Cedars-Sinai Medical Center ( Site 0110), Los Angeles, California, United States
- Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130), Chicago, Illinois, United States
- Northwestern Medicine Cancer Center - Warrenville ( Site 0134), Warrenville, Illinois, United States
- University of Iowa ( Site 0104), Iowa City, Iowa, United States
- Johns Hopkins Hospital-Sidney Kimmel Comprehensive Cancer Center - Developmental Therapeutics ( Site 0108), Baltimore, Maryland, United States
- National Institutes of Health ( Site 0125), Bethesda, Maryland, United States
- Massachusetts General Hospital ( Site 0111), Boston, Massachusetts, United States
- University of Michigan ( Site 0126), Ann Arbor, Michigan, United States
- Washington University-Internal Medicine/Oncology ( Site 0124), St Louis, Missouri, United States
- Icahn School of Medicine at Mount Sinai ( Site 0123), New York, New York, United States
- Penn Medicine: University of Pennsylvania Health System-Heme/Onc ( Site 0127), Philadelphia, Pennsylvania, United States
- SCRI Oncology Partners ( Site 7000), Nashville, Tennessee, United States
- Vanderbilt University Medical Center ( Site 0107), Nashville, Tennessee, United States
- University of Texas MD Anderson Cancer Center ( Site 0112), Houston, Texas, United States
- Prince of Wales Hospital-Medical Oncology ( Site 1601), Randwick, New South Wales, Australia
- The Royal Melbourne Hospital ( Site 1602), Parkville, Victoria, Australia
- Arthur J.E. Child Comprehensive Cancer Centre ( Site 0203), Calgary, Alberta, Canada
- Princess Margaret Cancer Centre ( Site 0202), Toronto, Ontario, Canada
- FALP ( Site 2200), Santiago, Region M. de Santiago, Chile
- Centro de Oncología de Precisión ( Site 2203), Santiago, Region M. de Santiago, Chile
- Peking University First Hospital-Urology ( Site 1900), Beijing, Beijing Municipality, China
- Sun Yat-sen University Cancer Center ( Site 1905), Guangzhou, Guangdong, China
- Renji Hospital Shanghai Jiao Tong University School of Medicine ( Site 1904), Shanghai, Shanghai Municipality, China
- West China Hospital of Sichuan University ( Site 1906), Chengdu, Sichuan, China
- Rigshospitalet ( Site 0304), Copenhagen, Capital Region, Denmark
- Rigshospitalet-Department of Endocrinology ( Site 0303), Copenhagen, Capital Region, Denmark
- Odense Universitetshospital ( Site 0302), Odense, Region Syddanmark, Denmark
- CHU Strasbourg-Hautepierre-Medecine Interne, Endocrinologie et Nutrition ( Site 0402), Strasbourg, Alsace, France
- Hôpital Edouard Herriot-oncologie ( Site 0405), Lyon, Auvergne-Rhône-Alpes, France
- Institut Paoli-Calmettes-Oncology ( Site 0406), Marseille, Bouches-du-Rhone, France
- Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre ( Site 0407), Le Kremlin-Bicêtre, Paris, France
- Hopitaux Universitaires Paris Centre-Hopital Cochin ( Site 0404), Paris, France
- Gustave Roussy ( Site 0403), Villejuif, Île-de-France Region, France
- Klinikum der Ludwig-Maximilians-Universitaet Muenchen-Department of Internal Medicine IV, Division ( Site 0501), München, Bavaria, Germany
- Comprehensive Cancer Center Mainfranken-Div. of Endocrinology and Diabetes ( Site 0500), Würzburg, Bavaria, Germany
- Universitaetsklinikum Freiburg ( Site 0504), Freiburg, Brandenburg, Germany
- Universitaetsklinikum Duesseldorf-Gastroenterology, Hepatology and Infectiology ( Site 0505), Düsseldorf, North Rhine-Westphalia, Germany
- Charité Universitaetsmedizin Berlin - Campus Mitte-Department of Endocrinology and Metabolism ( Site 0503), Berlin, Germany
- Semmelweis University-Belgyógyászati és Onkológiai Klinika Hematológia Osztály ( Site 0600), Budapest, Hungary
- Sheba Medical Center-Institute of Endocrinology, Diabetes and Metabolism ( Site 1400), Ramat Gan, Israel
- Sourasky Medical Center ( Site 1401), Tel Aviv, Israel
- University of Naples Federico II-Dipartimento di Medicina Clinica e Chirurgia ( Site 0704), Naples, Campania, Italy
- Fondazione IRCCS Istituto Nazionale dei Tumori-S.C. Oncologia Medica 2- Sarcomi ( Site 0709), Milan, Lombardy, Italy
- Azienda Ospedaliero Universitaria Senese-U.O.C. Immunoterapia Oncologica ( Site 0706), Siena, Tuscany, Italy
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 0708), Bologna, Italy
- Azienda Ospedaliera Spedali Civili di Brescia-Oncology ( Site 0701), Brescia, Italy
- Ospedale San Raffaele-Oncologia Medica ( Site 0705), Milan, Italy
- Istituto Europeo di Oncologia IRCCS-Divisione di Oncologia Medica Gastrointestinale e Tumori Neuroe ( Site 0700), Milan, Italy
- Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Roma ( Site 0703), Verona, Italy
- Hokkaido University Hospital ( Site 1800), Sapporo, Hokkaido, Japan
- Yokohama City University Hospital ( Site 1804), Yokohama, Kanagawa, Japan
- Kochi Medical School Hospital ( Site 1807), Nankoku, Kochi, Japan
- National Cancer Center Hospital ( Site 1802), Chuo-ku, Tokyo, Japan
- Kyoto University Hospital ( Site 1806), Kyoto, Japan
- Tokyo Women's Medical University Adachi Medical Center ( Site 1803), Tokyo, Japan
- Universitair Medisch Centrum Utrecht ( Site 1530), Utrecht, Netherlands
- Oslo Universitetssykehus Radiumhospitalet ( Site 2400), Oslo, Norway
- START Lisbon - Hospital de Santa Maria ( Site 2601), Lisbon, Lisbon District, Portugal
- Instituto Portugues de Oncologia Do Porto Francisco Gentil E.P.E. ( Site 2600), Porto, Portugal
- GBUZ Republican Clinical Oncological Dispensary ( Site 0804), Ufa, Baskortostan, Respublika, Russia
- Saint Petersburg State University-Clinic of advanced medical technologies n. a. Nicolay I. Pirogov ( Site 0805), Saint Petersburg, Leningradskaya Oblast', Russia
- Saint-Petersburg City Clinical Oncology Dispensary-Department of chemotherapy ( Site 0803), Saint Petersburg, Leningradskaya Oblast', Russia
- Fed State Budgetary Inst N.N. Blokhin Med Center of Oncology MHRF ( Site 0801), Moscow, Moscow, Russia
- Endocrinology Research Center of Rosmedtechnologies-Surgery ( Site 0809), Moscow, Moscow, Russia
- National Cancer Centre Singapore ( Site 1700), Singapore, Central Singapore, Singapore
- Seoul National University Hospital ( Site 2001), Jongno-gu, Seoul, South Korea
- Asan Medical Center ( Site 2000), Songpa-gu, Seoul, South Korea
- MD Anderson Cancer Center-Oncology ( Site 1102), Madrid, Madrid, Comunidad de, Spain
- Hospital Universitario 12 de Octubre-Medical Oncology ( Site 1103), Madrid, Madrid, Comunidad de, Spain
- Hospital Universitario Central de Asturias-Medical Oncology ( Site 1101), Oviedo, Principality of Asturias, Spain
- Hospital Universitari Vall d'Hebron ( Site 1100), Barcelona, Spain
- Skanes University Hospital Lund ( Site 1200), Lund, Skåne County, Sweden
- Karolinska Universitetssjukhuset Solna ( Site 1202), Stockholm, Stockholm County, Sweden
- Akademiska sjukhuset-Blod- och tumörsjukdomar ( Site 1201), Uppsala, Uppsala County, Sweden
- Sahlgrenska Universitetssjukhuset-Department of Oncology CTU Clinical Trial Unit ( Site 1204), Gothenburg, Västra Götaland County, Sweden
- Baskent University Adana Training Hospital ( Site 0906), Yüreğir, Adana, Turkey (Türkiye)
- Ege University Medicine of Faculty ( Site 0900), Bornova, İzmir, Turkey (Türkiye)
- Hacettepe Universitesi-oncology hospital ( Site 0901), Ankara, Turkey (Türkiye)
- Ankara Bilkent Şehir Hastanesi. ( Site 0904), Ankara, Turkey (Türkiye)
- Istanbul Universitesi Cerrahpasa-Medical Oncology ( Site 0902), Istanbul, Turkey (Türkiye)
- Addenbrooke's Hospital ( Site 1309), Cambridge, Cambridgeshire, United Kingdom
- Royal Free Hospital ( Site 1302), London, England, United Kingdom
- The Beatson West of Scotland Cancer Centre ( Site 1308), Glasgow, Glasgow City, United Kingdom
- Hammersmith Hospital-Medical Oncology ( Site 1304), London, London, City of, United Kingdom